טמו 180 מ"ג

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

TEMOZOLOMIDE 180 MG

Tersedia dari:

PERRIGO ISRAEL AGENCIES LTD

Kode ATC:

L01AX03

Bentuk farmasi:

CAPSULES

Rute administrasi :

PER OS

Diproduksi oleh:

HAUPT PHARMA AMAREG GMBH, GERMANY

Kelompok Terapi:

TEMOZOLOMIDE

Indikasi Terapi:

Temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Tanggal Otorisasi:

2011-11-01